149 related articles for article (PubMed ID: 25198486)
1. The nature and pattern of coronary stent recalls.
Kumar S; Innasimuthu AL; Marmur JD
J Invasive Cardiol; 2014 Sep; 26(9):433-6. PubMed ID: 25198486
[TBL] [Abstract][Full Text] [Related]
2. Overview of high-risk medical device recalls in obstetrics and gynecology from 2002 through 2016: implications for device safety.
Janetos TM; Ghobadi CW; Xu S; Walter JR
Am J Obstet Gynecol; 2017 Jul; 217(1):42-46.e1. PubMed ID: 28500861
[TBL] [Abstract][Full Text] [Related]
3. An exploratory analysis of U.S. FDA Class I medical device recalls: 2014-2018.
Sarkissian A
J Med Eng Technol; 2018 Nov; 42(8):595-603. PubMed ID: 30896310
[TBL] [Abstract][Full Text] [Related]
4. Overview of Class I Device Recalls in Diagnostic Radiology, 2002-2015.
Ghobadi CW; Hayman EL; Xu S
J Am Coll Radiol; 2016 Jun; 13(6):638-43. PubMed ID: 26922597
[TBL] [Abstract][Full Text] [Related]
5. Medical Device Recalls in Radiation Oncology: Analysis of US Food and Drug Administration Data, 2002-2015.
Connor MJ; Tringale K; Moiseenko V; Marshall DC; Moore K; Cervino L; Atwood T; Brown D; Mundt AJ; Pawlicki T; Recht A; Hattangadi-Gluth JA
Int J Radiat Oncol Biol Phys; 2017 Jun; 98(2):438-446. PubMed ID: 28463163
[TBL] [Abstract][Full Text] [Related]
6. 5-year results of a randomized comparison of XIENCE V everolimus-eluting and TAXUS paclitaxel-eluting stents: final results from the SPIRIT III trial (clinical evaluation of the XIENCE V everolimus eluting coronary stent system in the treatment of patients with de novo native coronary artery lesions).
Gada H; Kirtane AJ; Newman W; Sanz M; Hermiller JB; Mahaffey KW; Cutlip DE; Sudhir K; Hou L; Koo K; Stone GW
JACC Cardiovasc Interv; 2013 Dec; 6(12):1263-6. PubMed ID: 24239202
[TBL] [Abstract][Full Text] [Related]
7. Blood product recalls in the United States.
McCullough J; Riley E; Lindgren B; Pulkrabek S; Hall R; Riley W
Transfusion; 2014 Sep; 54(9):2276-82. PubMed ID: 24863173
[TBL] [Abstract][Full Text] [Related]
8. Error Types and Associations of Clinically Significant Events Within Food and Drug Administration Recalls of Linear Accelerators and Related Products.
Jairam V; Lincoln HM; Brown DW; Park HS; Evans SB
Pract Radiat Oncol; 2020; 10(1):e8-e15. PubMed ID: 31408733
[TBL] [Abstract][Full Text] [Related]
9. Clinical outcome of patients with and without diabetes mellitus after percutaneous coronary intervention with the resolute zotarolimus-eluting stent: 2-year results from the prospectively pooled analysis of the international global RESOLUTE program.
Silber S; Serruys PW; Leon MB; Meredith IT; Windecker S; Neumann FJ; Belardi J; Widimsky P; Massaro J; Novack V; Yeung AC; Saito S; Mauri L
JACC Cardiovasc Interv; 2013 Apr; 6(4):357-68. PubMed ID: 23523454
[TBL] [Abstract][Full Text] [Related]
10. Recalls of cardiac implants in the last decade: what lessons can we learn?
Zhang S; Kriza C; Schaller S; Kolominsky-Rabas PL;
PLoS One; 2015; 10(5):e0125987. PubMed ID: 25962074
[TBL] [Abstract][Full Text] [Related]
11. Characteristics of FDA drug recalls: A 30-month analysis.
Hall K; Stewart T; Chang J; Freeman MK
Am J Health Syst Pharm; 2016 Feb; 73(4):235-40. PubMed ID: 26843501
[TBL] [Abstract][Full Text] [Related]
12. Patient-related adverse events and device failures associated with commercially available enteral or duodenal self-expanding metal stents: an analysis of the MAUDE database.
Kennington D; Ramai D; Adler DG
Gastrointest Endosc; 2023 Feb; 97(2):309-313. PubMed ID: 36220381
[TBL] [Abstract][Full Text] [Related]
13. Blood component recalls in the United States.
Ramsey G; Sherman LA
Transfusion; 1999 May; 39(5):473-8. PubMed ID: 10335996
[TBL] [Abstract][Full Text] [Related]
14. [Analysis of FDA medical device recall in 2005-2006].
Zhang Q; Liu S; Yan Y; Fang P
Zhongguo Yi Liao Qi Xie Za Zhi; 2011 Jul; 35(4):280-3. PubMed ID: 22097754
[TBL] [Abstract][Full Text] [Related]
15. Medical Device Recalls in Orthopedics: Recent Trends and Areas for Improvement.
Vajapey SP; Li M
J Arthroplasty; 2020 Aug; 35(8):2259-2266. PubMed ID: 32279947
[TBL] [Abstract][Full Text] [Related]
16. Two-year outcomes after first- or second-generation drug-eluting or bare-metal stent implantation in all-comer patients undergoing percutaneous coronary intervention: a pre-specified analysis from the PRODIGY study (PROlonging Dual Antiplatelet Treatment After Grading stent-induced Intimal hyperplasia studY).
Valgimigli M; Tebaldi M; Borghesi M; Vranckx P; Campo G; Tumscitz C; Cangiano E; Minarelli M; Scalone A; Cavazza C; Marchesini J; Parrinello G;
JACC Cardiovasc Interv; 2014 Jan; 7(1):20-8. PubMed ID: 24332420
[TBL] [Abstract][Full Text] [Related]
17. Research: Evaluation of Orthopedic Hip Device Recalls by the FDA from 2007 to 2017.
Peters W; Pellerin C; Janney C
Biomed Instrum Technol; 2020 Nov; 54(6):418-426. PubMed ID: 33339030
[TBL] [Abstract][Full Text] [Related]
18. Major FDA medical device recalls in ophthalmology from 2003 to 2015.
Talati RK; Gupta AS; Xu S; Ghobadi CW
Can J Ophthalmol; 2018 Apr; 53(2):98-103. PubMed ID: 29631834
[TBL] [Abstract][Full Text] [Related]
19. Recent progress in percutaneous coronary intervention: evolution of the drug-eluting stents, focus on the XIENCE V drug-eluting stent.
Doostzadeh J; Clark LN; Bezenek S; Pierson W; Sood PR; Sudhir K
Coron Artery Dis; 2010 Jan; 21(1):46-56. PubMed ID: 19952925
[TBL] [Abstract][Full Text] [Related]
20. Latin American randomized trial of balloon angioplasty versus coronary stenting in diabetic patients with small vessel reference size (Latin American Small Vessel [LASMAL II] Trial): immediate and long-term results.
Rodriguez AE; Rodriguez Alemparte M; Fernandez Pereira C; Vigo CF; Sampaolesi A; Bernardi V; Marchand E; Tronge J; Palacios IF;
Am Heart J; 2005 Jul; 150(1):188. PubMed ID: 16086559
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
